Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Limagrain is one of the world’s largest seed companies (#4 globally) with a strong focus on research-driven development of new field crop and vegetable varieties. The company invests heavily in plant biotechnology—including GMOs where permitted—and has developed proprietary platforms like Hydraneo for drought resistance. It operates globally with over 9,000 employees across more than 40 countries. Its pipeline consists of thousands of commercialized seed varieties spanning major crops such as maize/corn, wheat, sunflower, barley, vegetables etc., with ongoing innovation targeting improved yield stability under climate stressors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Limagrain.